Current location - Education and Training Encyclopedia - Resume - Wang Xian's resume
Wang Xian's resume
Born in May, 1965, doctor of medicine, postdoctoral fellow in cardiovascular disease, chief physician, professor, doctoral supervisor, director of the Institute of Cardiovascular Disease of Beijing University of Chinese Medicine, director of the Department of Cardiovascular Medicine of the First Affiliated Hospital of Beijing University of Chinese Medicine (Dongzhimen Hospital) and director of the Heart Center.

From 2003 to 2005, he conducted postdoctoral research under the guidance of Professor Hu Dayi. In 2004, he visited major heart centers such as the United States and Japan to study cardiovascular interventional therapy. From 2005 to 2065438+00, he served as Director of Cardiovascular Department of General Hospital of Beijing Military Region, Director of National Cardiovascular Pharmacology Base and Director of Cardiovascular Intervention Training Base of the whole army. He is good at interventional therapy of cardiovascular diseases, diagnosis of cardiovascular emergencies and treatment of integrated traditional Chinese and western medicine. He has successfully treated patients with cardiac arrest 18 minutes and many patients with cardiac rupture, and successfully saved countless precious lives, including senior generals of our army and academicians of China Academy of Engineering. He has been reported by many media such as CCTV and Health News, and is known as a "miracle worker". More than 4,000 cases of coronary stent implantation, 2,000 cases of interventional therapy for congenital heart disease and nearly 1000 cases of peripheral artery stent implantation have been completed, helping more than 80 hospitals in China to carry out interventional therapy for cardiovascular diseases. In view of clinical acute cardiovascular and cerebrovascular events, the academic circles first put forward the hypothesis of atherosclerosis "collateral wind moving internally" Under the guidance of this hypothesis, the hospital preparation and compound Chinese medicine monomer coated stent have entered the preclinical research of new drugs (devices). Published academic papers 103, of which 3 were included in SCI, 4 were translated by the chief editor and 3 were national invention patents.